Reduction of full-length transglutaminase 2 (TG2-L) expression decreases cisplatin chemoresistance in an MCF-7 model of hormone-positive breast cancer
Year: 2019
Session type: Poster / e-Poster / Silent Theatre session
Theme: Late breaking: Cancer discovery and underpinning research